Introduction
Airway disease is the major cause of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive disease caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. CFTR has several functions including that of a cAMPregulated chloride (Cl À ) channel. Gene therapy has the potential to be an effective treatment for CF, and an in vitro study has suggested that approximately 6-10% of cells need to be corrected to restore maximal Cl À transport function. 1 Similarly, an in vivo study has shown that approximately 5% of normal levels of CFTR gene expression can both correct the chloride abnormality and, importantly, the intestinal pathology seen in CF mice. 2 Both preclinical studies and clinical trials of gene therapy for CF have indicated that transfer of the CFTR gene can partially correct the chloride defect. However, in none of these studies has sodium hyperabsorption been shown to be altered and it is generally considered that this is due to the low gene transfer efficiency of the currently available vectors, including adeno-associated virus, adenovirus and non-viral vectors. 3 In turn, this likely relates to a series of extra-and intracellular barriers that the respiratory epithelium has evolved to prevent penetration of lumenally delivered substances (reviewed in reference 3 ). Two different approaches have been adopted to overcome these barriers. The first aims to modify the host by using (1) mucolytic agents, 4, 5 (2) agents that allow access to the basolateral surface where most of the viral receptors are located 6, 7 or (3) agents that reduce intracellular degradation of gene transfer vectors. 8 The second modifies the gene transfer agent. Thus, vectors have been developed which recognize receptors on the apical surface of airway epithelial cells. [9] [10] [11] We have developed a recombinant Sendai virus (SeV) that recognizes a sialic acid containing receptor on the surface of airway epithelial cells, and avoids many of the extra-and intracellular barriers known to limit airway gene transfer. 3 SeV was shown to mediate delivery of reporter genes such as LacZ and luciferase 12 as well as therapeutic genes such as interleukin-10 13 to the airway epithelium in vivo with high efficiency. Here, for the first time we show that the CFTR cDNA can be inserted within SeV and, importantly, be delivered to airway epithelial cells both in vitro and to CF knockout mice in vivo.
Results

Insertion of CFTR cDNA into SeV induces mutations
SeV-CFTR vectors were constructed by inserting the 4.5 kb CFTR cDNA into the SeV cDNA plasmid which was amplified by PCR from 5 0 to 3 0 NotI-tagged primers. However, when infectious viral particles were recovered, mutations in all clones were found ( Table 1) . 'Hot spots' were found around nucleotides 1257 and 3905 of the CFTR cDNA-derived sequence. Interestingly, when the regions were analysed, sequences matched those of SeVspecific end/transcription termination signals (E) and of the trinucleotide (CTT) intergenic (I) sequences of each of the six SeV genes (Figure 1a ). This combination of sequence homologies may have promoted the insertion of mutations within the CFTR cDNA-derived sequence, thus leading to non-functional CFTR channels (as defined by lack of forskolin/IBMX-stimulated I 125 efflux -data not shown).
Insertion of silent mutations into the CFTR cDNA leads to production of a fully mature CFTR protein channel that mediates chloride efflux
To avoid insertion of mutations in the CFTR 'hot spots' during vector amplification, we introduced silent mutations (nucleotide, but not amino acid changes) into the CFTR cDNA (Figure 1b ). Reverse and forward PCR primers were constructed around nucleotides 1257 and 3905 in order to alter the 'hot spot' sequences, without modifying the CFTR amino acid sequence (Arg-Lys-Thr around nucleotide 1257 and Arg-Lys-Asn around nucleotide 3905). The 4.5 kb CFTR cDNA was inserted into a pSeV/MF plasmid between the M and F genes of the SeV genome, and an F gene-derived start signal was used to drive its expression (SeV/CFTRm'F).
SeV-mediated CFTR activity in vitro was measured using an assay based on the 3 0 -5 0 -cAMP-mediated efflux of halide through the CFTR channel. C127 cells were transduced in vitro with SeV. The cAMP agonist (forskolin and the phosphodiesterase inhibitor IBMX)-mediated I 125 efflux was then assessed 48 h post-gene transfer. As shown in Figure 2 , no I 125 efflux was seen in untransduced C127 cells or cells transduced with a control SeV carrying a mutated CFTR (SeV-mutCFTR). A significant I 125 efflux response 1 min after forskolin/ IBMX stimulation was observed only in C127 cells transduced with SeV/CFTRm'F (Po0.001). To identify the channel responsible for the halide efflux, we used the perforated whole-cell patch-clamp technique. Continual stimulation (for up to 6 min) failed to elicit an increase in mean current density in cells (n ¼ 7) transduced with a control vector expressing b-galactosidase (SeV-LacZ) (Figures 3a and c) . In contrast, in 10 out of 11 cells transduced with SeV/CFTRm'F, the mean current density at E rev +60 mV increased from 6.2871.03 pA/pF to 61.4277.16 pA/pF, on addition of the cAMP cocktail (Figures 3b and c) . The mean E rev for this current was À2.97 mV, close to the calculated value for E Cl of À7.8 mV. Following current stimulation, 100 mM of bath NaCl was replaced with equimolar NaBr, NaI or Na-aspartate, and the anion selectivity sequence of the channel was shown to be Br
À based on shifts in reverse potential. Pharmacological characterization showed the current to be insensitive to 500 mM 4,4-diisothiocyanatostilbene-2,2-disulfonic acid (DIDS) (n ¼ 7). However, the current was significantly reduced by 80.173.9% in the presence of 500 mM diphenylamine-2-carboxylic acid (DPC) (E rev +60 mV, n ¼ 5). Together, these are the characteristic responses of CFTR. ] is not equal on both sides of the membrane. Assuming that the channel is chloride selective, and that the membrane potential is À40 mV, the true E rev would be À17.7 mV. Given an external [Cl À ] of 114 mM, this corresponds to an intracellular Cl À concentration of 56.6 mM. Both wholecell and single-channel patch-clamp recordings are therefore consistent with those of a CFTR channel.
14 Perfusion of CF mouse nasal epithelium with SeV/CFTRm'F leads to partial correction of chloride transport in vivo Although CF knockout mice do not develop CF-like lung disease, their nasal epithelium displays the characteristic ion channel abnormalities, that is, increased baseline potential difference (PD), mainly due to increased sodium absorption, and decreased responses to lowchloride solutions, due to absent CFTR chloride transport. To assess SeV-mediated CFTR expression in vivo, the nasal epithelium of CF knockout mice was transduced with SeV/CFTRm'F (5 Â 10 7 PFU/mouse, n ¼ 12) or control vectors and the nasal PD was measured 2, 7, 14 and 28 days post-gene transfer. SeV/CFTRm'F transduced mice had a significantly (Po0.05) increased response to perfusion with a low-chloride solution (a measure of CFTR channel activity) 7 days after transduction compared to SeV-control treated mice (Figure 5a ). This represents approximately 7% correction towards wild-type values (16.972.0 mV) and was lost by 14 days after transduction. No significant change in low-chloride response was seen in SeV-control treated mice. Baseline PD fell significantly (Po0.01) in both SeV/CFTRm'F and SeV-control treated mice by day 7 ( Figure 5b ) and returned to pretreatment values by day 28. Responses to amiloride paralleled these changes (data not shown). It has been well recognized that inflammation, which perturbs the epithelial cell layer, can lead to a reduction in baseline PD. 15 We, therefore, assessed the integrity of the nasal epithelium following SeV transduction.
SeV/CFTRm'F is more inflammatory than an SeV-control vector Desquamation and hydropic degeneration of surface epithelial cells are often observed during virus infection. 16, 17 To assess SeV-associated effects we evaluated the extent of epithelial damage in mice transduced with SeV/CFTRm'F or with a SeV-control vector. Similar changes were seen in both groups (SeV/CFTRm'F: 2.370.2; SeV-control: 1.570.5 arbitrary units, n ¼ 6) 8 days after vector administration. However, infiltration of inflammatory cells into the surface epithelial layer (SeV/ CFTRm'F: 2.070.1; SeV-control: 0.970.1 arbitary units; n ¼ 6, Po0.01) and subepithelial area (SeV/CFTRm'F: 2.070.1; SeV-control: 1.370.2 arbitary units, n ¼ 6, Po0.01) were significantly increased in SeV/CFTRm'F Figure 6 ). Thus, treatment with SeV-CFTR clearly produces additional changes over and above those observed with a SeV-control vector, likely related to SeV-mediated overexpression of CFTR.
Second-generation transmission-incompetent SeV also lead to partial correction of chloride transport
We also transduced the nasal epithelium of CF knockout mice with a second-generation transmission incompetent fusion (F) protein-deleted SeV vector 18 (5 Â 10 7 PFU/ animal) carrying the CFTR gene (DF/SeV-CFTR/GFP; n ¼ 6) or control vector (DF/SeV-GFP; n ¼ 5). Nasal PD was measured 2 and 7 days after transduction. Similar to previous results chloride transport was significantly increased (Po0.01) 2 days after transduction when compared to controls (DF/SeV-CFTR/GFP: 0.5870.79 mV; DF/SeV-GFP: À2.9070.55 mV). However, baseline PD again fell in both DF/SeV-CFTR/GFP and control treated animals (DF/SeV-CFTR/GFP: 16.1872.39 mV; DF/SeV-GFP: 12.9672.67 mV). Thus, second-generation DF/SeV-CFTR led to similar changes in ion transport as the first-generation vector.
Discussion
We and others have shown that SeV is very efficient at delivering reporter and therapeutic genes to a variety of organs including muscle, lung, liver and brain. Here, we show that (1) SeV can be manipulated to accommodate the 4.5 kb CFTR cDNA, (2) this gives rise to a functional transmembrane protein and (3) SeV can mediate CFTR gene transfer to airway epithelial cells both in vitro and in vivo with consequent electrophysiological changes. However, this highly efficient vector leads to CFTRmediated toxicity as well as virus-induced inflammation.
One of the major challenges we encountered was to accommodate the comparatively large CFTR cDNA within the SeV genome. Recovered SeV viral particles, despite being infectious, contained mutations in the CFTR sequence affecting the ability to produce a fully mature CFTR channel. Interestingly, mutations were localized around 'hot spots' with sequences matching those of SeV-specific transcription termination signals. Sequence homology may have, therefore, encouraged the insertion of mutations within the CFTR sequence, leading to inactive or truncated CFTR channels. To our knowledge, this is one of the first examples in which mutations introduced by the virus replication machinery lead to silencing of the therapeutic gene. This might have been enhanced by the large size of the cDNA (4.5 kb) or toxicity associated with CFTR production during viral rescue and production.
In the present study we provided proof-of-principle that insertion of silent mutations into the CFTR sequences that resemble SeV end and intergenic Significant partial correction (*Po0.05) was only observed at day 7 when compared to response obtained in control group. (b) Variations in basal transmembrane potential difference after gene transfer. No significant difference was observed between the traces of the two groups at any time point. Numbers in brackets indicate animal numbers studied (SeV/CFTRm'F: pre: n ¼ 12, day 2: n ¼ 11, day 7: n ¼ 11, day 14: n ¼ 3, day 28: n ¼ 3; SeV-control: pre: n ¼ 16, day 2: n ¼ 16, day 7: n ¼ 15, day 14: n ¼ 8, day 28: n ¼ 6). Sendai virus-mediated CFTR gene transfer S Ferrari et al sequences circumvented mutagenesis of the cDNA during virus replication and led to efficient production of CFTR chloride channels in vitro and in vivo. It is currently unclear if mutagenesis is a phenomenon particularly associated with SeV vectors. Other negativestrand RNA viruses such as RSV 10 or human parainfluenza virus, 19 which are also used for gene therapy applications, may face similar issues. Identification and mutation of transgene sequences that affect amplification of negative-strand RNA viruses might, therefore, be an issue for these vectors.
Whole-cell patch-clamp experiments identified a forskolin-activated current in C127 cells transduced with SeV/CFTRm'F that was absent in the SeV-LacZ transduced cells. The selectivity sequence of I À 4Br À 4 aspartate À was typical of the CFTR chloride channel. Inhibitor studies demonstrated a DIDS insensitive, DPCsensitive current. Taken together, these data suggested that the channel observed was CFTR.
14 Cell-attached single-channel recording showed the channel to be voltage insensitive with a conductance of 2.6 pS. This was initially thought to be surprisingly low since CFTR is often quoted as having a conductance of 8 pS.
14 However, temperature can have a marked effect on channel conductance. 20 As these experiments were conducted at room temperature, the conductance would be expected to be reduced. In addition, there is a relationship between the conductance of CFTR and the Cl À concentration. In excised patches bathed in symmetrical Cl À , Tabcharani et al. 20 described a concentration response curve in which as the concentration of Cl À is lowered the conductance of the channel falls (K m ¼ 37.6 mM). Extrapolation of our data indicates a reversal potential, E rev , of À22.1 mV. Assuming a membrane potential of À40 mV and a Cl À -selective channel, the Nernst equation would therefore predict the internal Cl À concentration to be 56.6 mM under our conditions. In symmetrical 50 mM Cl À , Tabcharani et al.
20
showed CFTR to have a conductance of around 6 pS (221C). In our cell-attached experiments, the gradient across the membrane, with 114 mM Cl À on the outside, may be predicted to further reduce the conductance. Practical constraints meant that recordings could only be obtained at positive holding potentials, allowing study of the inward current or Cl À efflux from the cell. Early work by Gray et al. 21 identified differences in the conductance of the inward and outward currents of human CFTR in cell-attached patches. There are reports in the literature that describe a conductance for CFTR at the level that we observed. Larsen et al. 22 expressed CFTR in Sf 9 cells via baculoviral transduction. In outside-out patches, they obtained a physiological conductance (40 mM Cl À in the pipette or intracellular solution, and 150 mM Cl À in the bath or extracellular solution) of 2.8 pS. The E rev of the current was -25 mV. These data corresponds well with our observations and our predicted values of intracellular Cl À concentration. Interestingly, it has been reported that large quantities of vectors can alter the physiological properties of CFTR. 23 The response to cAMP regulation as measured through whole-cell recording, and the regulation of the outwardly rectifying chloride channel by CFTR were shown to be affected. While our whole-cell data did not indicate any deviation from the expected responses it cannot be ruled out that the method of transduction has affected the single-channel properties of the CFTR.
SeV is likely the most efficient gene transfer agent for the airway epithelium and able to overcome many of the extra-and intracellular barriers known to limit gene transfer by other viral and non-viral vectors. At the dose used in this study, SeV is able to transduce close to 100% of airway epithelial cells. 13 Sodium absorption decreased between 2 and 7 days after transduction and returned to pretreatment values by day 28. However, this response was similar in both SeV-CFTR and control vector-treated mice and could, therefore, not be attributed to CFTR expression. Since ion transport across epithelial cells can be perturbed by inflammation, we hypothesized that inflammation may be the cause of the reduction in sodium transport. Both SeV-CFTR and control vectortreated mice showed a degree of epithelial damage and inflammation. It is important to note that SeV is a natural lung pathogen in mice but not in human, and data presented here may not be representative following transduction of a non-rodent species. In support of this, it has been reported that intranasal administration of wild-type SeV caused no apparent toxicity in African green monkeys 24 and humans. 25 Interestingly, a higher degree of inflammation and hydrodegeneration was observed in mice treated with the SeV-CFTR vector. These results may indicate a degree of cytotoxicity due to overexpression of CFTR in transduced cells. It is generally assumed that endogenous CFTR expression in most cells is comparatively low (approximately 20-100 channel proteins/cell) 26 and it is unclear how overexpression may lead to toxicity. A recent paper by Farmen et al. 27 indicated that overexpression of CFTR leads to redistribution of the protein to the basolateral membrane and shunting of apical chloride transport. One might speculate that overexpression of CFTR may also affect other functions of the protein leading to the increased inflammation observed in this study. This is supported by in vitro reports showing that high levels of CFTR activity can result in increased cell volume and subsequent cell growth abnormalities, 28 as well as arrest of cell division. 29 Despite the use of second-generation DF/SeV or SeV that due to the 'position effect' 30 characteristic of negative-strand RNA viruses were likely to produce lower levels of CFTR (data not shown), the reduction in baseline PD both after SeV-CFTR and control-vector infection remained a problem. We were therefore unable to determine whether SeV-mediated CFTR expression could lead to a CFTR-specific reduction in sodium absorption. In addition, we cannot exclude that the inflammation may also have interfered with the chloride transport measurements and may, in part, be responsible for the partial increase in chloride transport, despite efficient expression of CFTR.
In conclusion, we have been successful in constructing a recombinant SeV vector carrying the CFTR gene. CFTR chloride channel activity was confirmed in vitro and in vivo. However, a combination of SeV-mediated inflammation and CFTR overexpression-induced toxicity appears to interfere with ion transport measurements in vivo. Further modifications to the vector and host will make it easier to translate these studies into CF clinical trials. In support of this, we have now generated thirdand fourth-generation vectors in which viral genes have Sendai virus-mediated CFTR gene transfer S Ferrari et al been further deleted. 31, 32 A second strategy aimed at utilizing the efficient SeV-mediated transfection of airway epithelial cells is based on the use of SeV envelope proteins in other gene transfer vectors. We have, for example, succeeded in pseudotyping a lentiviral vector with the SeV F and HN proteins and shown efficient long-term transduction of airway epithelial cells. 33 
Materials and methods
SeV vectors construction
All SeV vectors (carrying both CFTR or reporter genes) were constructed by inserting PCR-amplified cDNAs using NotI-tagged primers into the SeV cDNA plasmid, pSeV18b(+), as previously described. 34, 35 When the fulllength CFTR cDNA was inserted, the following PCR primers were used:
Following the finding that SeV introduced mutations within the CFTR sequence, CFTR cDNA was amplified by using two pairs of PCR primers constructed around the 'hot spot' regions (nucleotides 1257 and 3905) and one pair of NotI-tagged terminal primers. Reverse and forward PCR primers constructed around nucleotides 1257 and 3905 were modified in order to alter the 'hot spots' sequences, but maintaining the original CFTR amino acid sequence (Arg-Lys-Thr around nucleotide 1257 and Arg-Lys-Asn around nucleotide 3905). The following PCR primers were used:
The CFTR cDNA was inserted between the M and F genes of SeV (SeV/CFTRm'F) and expression was driven by an F start signal. All SeV vectors (both those carrying a CFTR-derived sequence and a reporter gene) were recovered by reverse genetics, 36 propagated in embryonated chicken eggs as previously described 37 and stored at À801C. DF/SeV-CFTR/GFP fusion and DF/SeV-GFP were constructed and propagated as previously described. 18 Cell culture C127 cells (a kind gift of Dr SH Cheng, Genzyme Corporation, Framingham, MA, USA) were maintained and propagated as previously described. 38, 39 Patch-clamp studies Whole-cell patch clamp. C127 cells were plated at 50 000 cells/coverslip and transduced with either the SeV-LacZ (control) or SeV/CFTRm'F vector at MOI (multiplicity of infection) ¼ 5. Forty-eight hours postinfection, the perforated whole-cell recording technique (amphotericin B permeabilized, 240 mg/ml) was used to record whole-cell currents. CFTR currents were stimulated with 30 mM forskolin and 100 mM IBMX. The pharmacology of the forskolin/IBMX-activated current was investigated using 500 mM DIDS and 500 mM DPC. Electrophysiology was carried out at room temperature as previously described. 40 Briefly, an EPC-7 amplifier (List Electronic, Darmstadt, Germany) was used to record whole-cell currents. Current/voltage (I/V) relationships were obtained by holding V m at 0 mV and clamping to 7100 mV in 20 mV increments for 500 ms, with a 800 ms interval between each pulse. Data were filtered at 1 kHz, sampled at 2 kHz with a CED 1401 interface (Cambridge Electronic Design, Cambridge, UK). V m was corrected for liquid junction potentials. Mean current amplitudes were calculated at E rev 760 mV and normalized to cell capacitance (pF).
Cell-attached single-channel recordings. C127 cells were plated at 20 000 cells/glass coverslips for use in patch-clamp experiments. Electrophysiology was carried out at 21-231C. In the cell-attached configuration, the PD across the patch is equal to the cell membrane potential minus the V p . Because the membrane potential is unknown, values are given as V p corrected for the junction potential value. Inward current, the flow of anions from the inside of the cell to the outside is represented by the downward deflection on each record. The Strathclyde Electrophysiology Software programme WinEDR was used for single-channel analysis to determine the open-state probability P O and the observed current i. Current records were low-pass filtered at 100 Hz. The sampling interval was 0.5 ms. Traces were analysed and an all points histogram for each experiment was constructed at each V p . From this, the current amplitude and open-state probability were determined. E rev were obtained from linear extrapolation of the current-voltage plot. The internal Cl À concentration was predicted from the Nernst equation. 
Iodide 125 efflux assay
SeV-mediated CFTR activity in vitro was measured using an assay based on the cAMP-mediated efflux of halide through the CFTR channel. Since cAMP-mediated chloride channels are more permeable to iodide than many other chloride transport processes, in this assay iodide 125 (I 125 , half-life ¼ 59.6 days) is conveniently used instead of the natural chloride radiotracer chlorine. 36 (half-life ¼ 300 000 years). Twenty-four hours before infection, C127 cells were plated on six-well plates at a seeding density of 10 4 cells/well. Infection with recombinant SeV was carried out at MOI ¼ 5, and CFTR Sendai virus-mediated CFTR gene transfer S Ferrari et al expression analysed at 48 h later. Cells were washed three times with efflux buffer (5 mM KCl, 140 mM NaCl, 1.3 mM CaCl 2 , 0.5 mM MgCl 2 , 10 mM HEPES (pH 7.4) and 5 mM glucose) and then exposed to the buffer containing 50 mCi/ml of I 125 (GE Healthcare UK Limited, Little Chalfont, Buckinghamshire, UK) for 90 min at 371C Efflux of radiotracer was measured every 1 min by rapidly removing efflux buffer and adding a further aliquot for a total period of 30 min. Cells were challenged with 30 mM of the cAMP agonist forskolin and 100 mM of the phosphodiesterase inhibitor IBMX by exchanging the efflux buffer with efflux buffer containing forskolin/ IBMX. Finally, 0.2 M NaOH was added for 30 min to remove any residual tracer. I 125 radioactivity was measured by g counting. Apparent rate constants k (min À1 ) were calculated as detailed previously. 41, 42 Mouse in vivo nasal PD measurements
Because of the limited availability of CF animals, a mixture of Cftr G551D mice (mixed gender and approximately 10 weeks of age, 43 ) and Cftr tm1Unc TgN (FABPCFTR)#Jaw mice 44 were used for nasal PD measurements. A fine-tip catheter (outer diameter: 0.5 mm) was placed at 2.5 mm into the nasal cavity and 100 ml of the solution containing appropriate titres of SeV was perfused at a rate of 5 ml/min using a peristaltic pump (P1 pump, GE Healthcare, Herts, UK). The in vivo nasal PD of the CF mice was determined 1 week before gene transfer (pretreatment PD), as previously described. 45 Briefly, a sequence of (1) HEPES-containing Kreb's solution (HK) plus amiloride and (2) low-chloride HK plus amiloride was perfused into the nasal cavity of CF mice at a rate of 21 ml/min using a peristaltic pump. The effects of perfusion of low-chloride HK solution were assessed after 5 min. The effects of SeV gene transfer on baseline traces and low-chloride responses were assayed 2, 7, 14 and 28 days after gene delivery. Please note that the decrease in animal numbers over time is due to either the CF mice not surviving repeated anaesthesia or death as a consequence of intestinal blockage during the course of the experiment.
Evaluation of airway epithelium injury and inflammation
Nasal turbinates were fixed in 4% paraformaldehyde, dehydrated and embedded in paraffin wax. Sections of 5 mm were cut and stained with haematoxylin-eosin (HE). The HE sections were observed using a Leitz Dialux 20 light microscope (Leitz GmbH, Wetzlar, Germany) working at Â 200 magnification and fitted with an eyepiece graticule divided into 100 squares. The eyepiece graticule was used to 'point count' and assess the percentage of surface epithelial injury and of epithelial/subepithelial areas with infiltration of inflammatory cells. 46 Scores of 0-3 were used to express the levels of epithelial injury and nasal mucosa inflammation: 0 ¼ 0% of areas showing injury and inflammation, 0.5 ¼ less than 10%, 1 ¼ between 10 and 30%, 2 ¼ between 30 and 60%, 3 ¼ more than 60%.
Statistical analysis
Statistical analysis was performed using a MannWhitney test. For patch-clamp studies, an analysis of variance (ANOVA) test was used. The null hypothesis was rejected at Po0.05.
